Article link : https://born2invest.com/articles/biotech-companies-leading-the-way-with-exosome-human-clinical-trials/

Born2Invest, a digital news organization on business and finance around the world, introduced EXO-CBio in February 2020 as the only Asian company to enter the full-time stage using 'Naveve' EXO-SOM.

 Biotech companies leading the way with exosome human clinical trials